Cargando…
Critical appraisal of ramelteon in the treatment of insomnia
Ramelteon is the first member of a novel class of hypnotics and acts as a selective melatonin receptor agonist. In 2005, ramelteon was approved by the US Food and Drug Administration for the treatment of insomnia characterized by sleep onset problems. Its unique mechanism of action made it a promisi...
Autores principales: | Mets, Monique AJ, van Deventer, Kenny R, Olivier, Berend, Verster, Joris C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3630951/ https://www.ncbi.nlm.nih.gov/pubmed/23616713 http://dx.doi.org/10.2147/NSS.S6846 |
Ejemplares similares
-
Pharmacotherapy of Insomnia with Ramelteon: Safety, Efficacy and Clinical Applications
por: Pandi-Perumal, Seithikurippu R., et al.
Publicado: (2011) -
Use of Melatonin and/on Ramelteon for the Treatment of Insomnia in Older Adults: A Systematic Review and Meta-Analysis
por: Marupuru, Srujitha, et al.
Publicado: (2022) -
Psychoactive Medication and Traffic Safety
por: Verster, Joris C., et al.
Publicado: (2009) -
Clinical evaluation of zaleplon in the treatment of insomnia
por: Ebbens, Marieke M, et al.
Publicado: (2010) -
The Melatonin Receptor Agonist Ramelteon Effectively Treats Insomnia and Behavioral Symptoms in Autistic Disorder
por: Kawabe, Kentaro, et al.
Publicado: (2014)